Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Pregabalin (Lyrica)

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44352   clinical trials with a EudraCT protocol, of which   7379   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    102 result(s) found for: Pregabalin (Lyrica). Displaying page 3 of 6.
    « Previous 1  2  3  4  5  6  Next»
    EudraCT Number: 2010-022955-43 Sponsor Protocol Number: A0081256 Start Date*: 2011-05-17
    Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
    Full Title: OPEN LABEL EUROPEAN STUDY TO SUPPORT THE EARLY IDENTIFICATION OF PATIENTS WITH CHRONIC NEUROPATHIC LOW BACK PAIN IN PRIMARY CARE AND TO ASSESS THE EFFECTIVENESS AND TOLERABILITY OF PREGABALIN IN TH...
    Medical condition: Pregabalin (Lyrica ®) is approved in the European Union for the treatment of peripheral and central neuropathic pain in adults. The medical condition being investigated in this study is chronic neu...
    Disease: Version SOC Term Classification Code Term Level
    13.1 10029205 - Nervous system disorders 10054095 Neuropathic pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Prematurely Ended) GR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-013642-80 Sponsor Protocol Number: TCAPGB Start Date*: 2009-09-30
    Sponsor Name:Department of Neurology, Odense University Hospital
    Full Title: Randomised, double-blind, placebo-controlled trial of the effect of the combination of imipramine and pregabalin for the treatment of painful polyneuropathy
    Medical condition: Painful polyneuropathy (idiopathic, diabetic, alcoholic, drug-induced and other etiologies)
    Disease: Version SOC Term Classification Code Term Level
    12.0 10036105 Polyneuropathy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2021-004417-40 Sponsor Protocol Number: ANeP01 Start Date*: 2022-02-28
    Sponsor Name:Helse Bergen HF
    Full Title: The effect of pregabalin in the treatment of acute post-operative peripheral neuropathic pain – a pilot study
    Medical condition: acute post-operative peripheral neuropathic pain
    Disease:
    Population Age: Adults, Elderly Gender:
    Trial protocol: NO (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-003656-11 Sponsor Protocol Number: A0081171 Start Date*: 2007-11-26
    Sponsor Name:Pfizer, S.A
    Full Title: ESTUDIO ALEATORIZADO, DOBLE CIEGO, MULTICÉNTRICO, DE DETERMINACIÓN DE DOSIS PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE PREGABALINA EN COMPARACIÓN CON PLACEBO COMO TRATAMIENTO COMPLEMENTARIO DEL DOL...
    Medical condition: DOLOR POSTOPERATORIO POST SURGICAL PAIN
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036236 Postoperative pain relief LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: ES (Completed) SE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-002483-28 Sponsor Protocol Number: SM3-05 Start Date*: 2005-08-03
    Sponsor Name:Dept. of Anaestesiology, University hospital in Glostrup
    Full Title: Effect of paracetamol versus paracetamol combined with pregabalin versus paracetamol combined with pregabalin and dexamethason on pain and opioid requirements in patients scheduled for a primary to...
    Medical condition: Patient scheduled for a primary total hipreplacement need postoperativ pain treatment. Morphine has side-effects: nausea, vomiting, sedation and dizziness. These sideeffekts are of couse unpleasant...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-002010-35 Sponsor Protocol Number: TinnEx Start Date*: 2006-12-14
    Sponsor Name:Prof. Herta Flor, Head of the Institute of Clinical and Cognitive Neuroscience
    Full Title: An Extinction Training in Tinnitus
    Medical condition: The effect of pregabalin on the success to reduce the interference by tinnitus by an extinction training is tested in chronic tinnitus sufferers.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-001779-35 Sponsor Protocol Number: 4 Start Date*: 2013-02-15
    Sponsor Name:University of Southampton
    Full Title: The effects of pregabalin augmentation of antidepressant drug on neuro-cognitive functioning in patients with generalized anxiety disorder
    Medical condition: Generalised anxiety disorder
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004873 10018105 Generalized anxiety disorder LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2009-016849-25 Sponsor Protocol Number: A0081047 Start Date*: 2010-03-15
    Sponsor Name:Pfizer Inc
    Full Title: A DOUBLE-BLIND, RANDOMIZED, MULTICENTER EFFICACY AND SAFETY STUDY OF PREGABALIN (LYRICA) AS MONOTHERAPY IN PATIENTS WITH PARTIAL SEIZURES
    Medical condition: Partial Seizures
    Disease: Version SOC Term Classification Code Term Level
    12.1 10061334 Partial seizures LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-011014-17 Sponsor Protocol Number: A0081165 Start Date*: 2009-08-26
    Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017, US
    Full Title: EFFECTS OF PREGABALIN ON SLEEP MAINTENANCE IN SUBJECTS WITH FIBROMYALGIA SYNDROME AND SLEEP MAINTENANCE DISTURBANCE: A RANDOMIZED PLACEBO-CONTROLLED 2-WAY CROSSOVER POLYSOMNOGRAPHY STUDY
    Medical condition: SLEEP MAINTENANCE IN SUBJECTS WITH FIBROMYALGIA SYNDROME AND SLEEP MAINTENANCE DISTURBANCE
    Disease: Version SOC Term Classification Code Term Level
    9.1 10016631 Fibromyalgia syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-001840-30 Sponsor Protocol Number: A0081101 Start Date*: 2006-12-20
    Sponsor Name:Pfizer Ltd
    Full Title: A 12-WEEK, OPEN-LABEL, SAFETY TRIAL OF PREGABALIN IN PATIENTS WITH FIBROMYALGIA
    Medical condition: Fibromyalgia
    Disease: Version SOC Term Classification Code Term Level
    8.1 10048439 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) IE (Completed) PT (Completed) DE (Completed) SE (Completed) DK (Completed) NL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-003006-29 Sponsor Protocol Number: A0081072 Start Date*: 2005-09-26
    Sponsor Name:Pfizer Limited
    Full Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of the Anxiolytic Efficacy of Pregabalin and Alprazolam IR in Subjects with Anxiety prior to Dental Procedure
    Medical condition: Anxiety prior to Dental Procedure
    Disease: Version SOC Term Classification Code Term Level
    8.0 10002758 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-003197-57 Sponsor Protocol Number: A0081181 Start Date*: 2012-11-09
    Sponsor Name:Pfizer Worldwide Research and Development
    Full Title: A MULTIPLE DOSE PHARMACOKINETIC OPEN-LABEL STUDY OF PREGABALIN (LYRICA) IN HEALTHY LACTATING WOMEN
    Medical condition: neuropathic pain associated with diabetic peripheral neuropathy postherpetic neuralgia neuropathic pain related to spinal cord injury (US), fibromyalgia (US, JP) treatment of central and periphe...
    Disease: Version SOC Term Classification Code Term Level
    15.1 10029205 - Nervous system disorders 10028005 Motor peripheral neuropathy LLT
    15.1 10029205 - Nervous system disorders 10054095 Neuropathic pain LLT
    15.1 10029205 - Nervous system disorders 10036376 Post herpetic neuralgia PT
    15.1 10029205 - Nervous system disorders 10067547 Diabetic peripheral neuropathic pain LLT
    15.1 10022117 - Injury, poisoning and procedural complications 10041552 Spinal cord injury PT
    15.1 10037175 - Psychiatric disorders 10018075 Generalised anxiety disorder PT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2010-024538-51 Sponsor Protocol Number: ssgt05 Start Date*: 2012-03-02
    Sponsor Name:Silvia Gil Trujillo
    Full Title: Study of the effects of pregabalin in postoperative pain control in general total intravenous anesthesia, general inhalation anesthesia and combined anesthesia after abdominal hysterectomy.
    Medical condition: The presence of acute postoperative pain remains a major cause of preoperative morbidity.The objective is to evaluate the analgesic efficacy of pregabalin in the postoperatory of abdominal hysterec...
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-004062-17 Sponsor Protocol Number: WS1702721 Start Date*: 2013-06-26
    Sponsor Name:Aristotle University of Thessaloniki
    Full Title: Efficacy of add-on pregabalin in the treatment of Generalized Anxiety Disorder comorbid with Major Depressive Disorder: a double-blind placebo-controlled study.
    Medical condition: Generalized Anxiety Disorder comorbid with major depressive disorder.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-004515-20 Sponsor Protocol Number: PAIKIPAIN Start Date*: 2015-12-31
    Sponsor Name:Vesa Kontinen
    Full Title: Targeted pain management based on patient specific risk assesment in ambulatory surgery
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004863 10054711 Postoperative pain LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-006339-31 Sponsor Protocol Number: A0081103 Start Date*: 2007-03-08
    Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United states [...]
    1. Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United states
    2. Pfizer Oy
    Full Title: AN 8 WEEK, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 3 TRIAL OF PREGABALIN (150 600 MG/DAY) IN THE ADJUNCTIVE TREATMENT OF PATIENTS WITH GENERALIZED ANXIETY DISORDER (GAD) WHO HAVE NOT OPTIMALLY RESP...
    Medical condition: Generalized Anxiety Disorder (GAD)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10018105 Generalized anxiety disorder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Prematurely Ended) HU (Prematurely Ended) CZ (Completed) EE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-010557-12 Sponsor Protocol Number: Version1.0/Jan2009 Start Date*: 2012-03-01
    Sponsor Name:The Pennine Acute Hospitals NHS Trust
    Full Title: A Single Blind, Randomised, Cross-over Study to Compare the Efficacy of Lidocaine 5% Plasters(Versatis) versus Pregabalin (Lyrica) in the Treatment of Complex Regional Pain Syndrome, Type 1.
    Medical condition: Complex regional pain syndrome type 1.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10064334 Complex regional pain syndrome Type I LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-019521-34 Sponsor Protocol Number: A0081180 Start Date*: 2010-11-03
    Sponsor Name:Pfizer Inc.
    Full Title: A 15 WEEK, RANDOMIZED, DOUBLE BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, FLEXIBLE-DOSE, SAFETY AND EFFICACY STUDY OF PREGABALIN IN ADOLESCENTS (12-17 YEARS OLD) WITH FIBROMYALGIA
    Medical condition: Fibromyalgia
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10048439 Fibromyalgia PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2004-001500-13 Sponsor Protocol Number: A0081012 Start Date*: 2005-01-24
    Sponsor Name:Pfizer Ltd.
    Full Title: An 8-week, multicentre, randomised, double-blind, placebo-controlled, flexible dose study of Pregabalin (300-600 mg/day) and Venlafaxine XR (75-225 mg/day) for the acute treatment of DSM-IV General...
    Medical condition: Generalized Anxiety Disorder
    Disease: Version SOC Term Classification Code Term Level
    7.0 10018105 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IE (Completed) SE (Completed) GB (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-001942-18 Sponsor Protocol Number: 199999999 Start Date*: 2005-07-22
    Sponsor Name:Organisation name was not entered
    Full Title: Peroraalinen pregabaliini tähystyksen avulla tehtävän kohdunpoiston jälkeisen kivunhoidon hallinnassa
    Medical condition: Tutkimukseen otetaan 90 laparoskooppiseen kohdunpoistoon tulevaa alle 70-vuotiasta potilasta, joilla BMI on alle 35.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Aug 02 09:57:01 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA